Bode C - Search Results

1

Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa.

Peter K, Graeber J, Kipriyanov S, Zewe-Welschof M, Runge MS, Kübler W, Little M, Bode C. Peter K, et al. Among authors: bode c. Circulation. 2000 Mar 14;101(10):1158-64. doi: 10.1161/01.cir.101.10.1158. Circulation. 2000. PMID: 10715263

2

Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin.

Bode C, Hudelmayer M, Mehwald P, Bauer S, Freitag M, von Hodenberg E, Newell JB, Kübler W, Haber E, Runge MS. Bode C, et al. Circulation. 1994 Oct;90(4):1956-63. doi: 10.1161/01.cir.90.4.1956. Circulation. 1994. PMID: 7923685

3

Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting.

Bode C, Hanson SR, Schmedtje JF Jr, Haber E, Mehwald P, Kelly AB, Harker LA, Runge MS. Bode C, et al. Circulation. 1997 Feb 18;95(4):800-4. doi: 10.1161/01.cir.95.4.800. Circulation. 1997. PMID: 9054733

4

Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase.

Hagemeyer CE, Tomic I, Weirich U, Graeber J, Nordt T, Runge MS, Bode C, Peter K. Hagemeyer CE, et al. Among authors: bode c. J Thromb Haemost. 2004 May;2(5):797-803. doi: 10.1111/j.1538-7836.2004.00697.x. J Thromb Haemost. 2004. PMID: 15099287 Free article.

5

Purifying antibody-plasminogen activator conjugates.

Bode C, Runge MS, Haber E. Bode C, et al. Bioconjug Chem. 1992 Jul-Aug;3(4):269-72. doi: 10.1021/bc00016a001. Bioconjug Chem. 1992. PMID: 1390979 Review. No abstract available.

6

Hybrid molecules: insights into plasminogen activator function.

Runge MS, Bode C, Haber E, Quertermous T. Runge MS, et al. Among authors: bode c. Mol Biol Med. 1991 Apr;8(2):245-55. Mol Biol Med. 1991. PMID: 1806766 Review.

7

Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator.

Bode C, Runge MS, Schönermark S, Eberle T, Newell JB, Kübler W, Haber E. Bode C, et al. Circulation. 1990 Jun;81(6):1974-80. doi: 10.1161/01.cir.81.6.1974. Circulation. 1990. PMID: 2111744

8

Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons.

Runge MS, Harker LA, Bode C, Ruef J, Kelly AB, Marzec UM, Allen E, Caban R, Shaw SY, Haber E, Hanson SR. Runge MS, et al. Among authors: bode c. Circulation. 1996 Sep 15;94(6):1412-22. doi: 10.1161/01.cir.94.6.1412. Circulation. 1996. PMID: 8823001

9

Attenuation by gemfibrozil of expression of plasminogen activator inhibitor type 1 induced by insulin and its precursors.

Nordt TK, Kornas K, Peter K, Fujii S, Sobel BE, Kübler W, Bode C. Nordt TK, et al. Among authors: bode c. Circulation. 1997 Feb 4;95(3):677-83. doi: 10.1161/01.cir.95.3.677. Circulation. 1997. PMID: 9024157

10

Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18).

Peter K, Schwarz M, Conradt C, Nordt T, Moser M, Kübler W, Bode C. Peter K, et al. Among authors: bode c. Circulation. 1999 Oct 5;100(14):1533-9. doi: 10.1161/01.cir.100.14.1533. Circulation. 1999. PMID: 10510057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,403 results

Search Page

Filters